At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 50 enrolled
Drug / intervention
Intranasal sufentanil/ketaminedrug
Likely dose
Intranasal sufentanil/ketamine 0,5 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children
Danish University of Pharmaceutical Sciences·interventional·Posted Jan 12, 2010·Updated Sep 17, 2014
In Brief
A Phase 2 clinical trial evaluating Intranasal sufentanil/ketamine for Pain. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The aim of the study is to investigate the absorption and clinical effect of nasal administration of an analgesic nasal spray containing sufentanil+ketamine for pain related to medical procedures in hospitalized children.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesDenmark
CollaboratorsRigshospitalet, Denmark
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2010
Enrollment StartApr 2010
Primary CompletionFeb 2013
TodayJul 2026
First PostedJan 12, 2010
Enrollment StartApr 1, 2010
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 16.5 years ago
Interventions
Intranasal sufentanil/ketaminedrug
Nasal spray sufentanil+ketamine, 0,5 microg/kg sufentanil+0,5 mg/kg ketamine, single dose